Product
∆9-tetrahydrocannabinol
1 clinical trial
2 indications
Indication
cannabisIndication
TetrahydrocannabinolClinical trial
Modulation of ∆9-tetrahydrocannabinol Acute Psychoactive Effects by Ranging Doses of Cannabidiol in Healthy, Occasional Cannabis Users: a Controlled, Triple Blind, Randomized, Cross-over StudyStatus: Not yet recruiting, Estimated PCD: 2025-07-31